Sections of the U.S. equities market (most stocks) have performed well, offering ongoing enticing opportunities despite the AI scare. Read more here.

Q4 2025 Earnings Call February 6, 2026 8:30 AM ESTCompany ParticipantsJoanne Freiberger - Senior VP of Investor Relations ...

And thank you all for joining us on today's conference call to discuss Karyopharm Therapeutics Inc.'s fourth quarter and full ...

RevPAR increased 1.9% thanks to a strong end of the year, with December RevPAR coming in well ahead of our prior expectations. December global RevPAR rose 2.8%, showing the strongest monthly year-over ...

In the rural Nebraska panhandle, elementary teachers at Kimball Public Schools have watched students as young as 5 throw ...